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black particles. The combined application of serum and 
shield before the administration of carbon black particles 
and subsequent washing led to their elimination from the 
skin samples. Conclusion: The application of barrier-enhanc-
ing formulations in combination with a cleanser may reduce 
the penetration of harmful airborne particulates by prevent-
ing their adhesion to the skin and facilitating their removal 
by subsequent washing with the cleanser.
© 2018 S. Karger AG, Basel
Introduction
In the present study, the protective efficacy of different 
topically applied skin products, i.e., serum, shield, and a 
cleanser, against the permanent deposition of potentially 
noxious particulate pollutants (<1 µm), such as traffic-re-
lated soot [1] on ex vivo porcine ear and human skin sam-
ples was investigated using laser scanning microscopy. 
Due to their small size and large surface per unit mass, 
these nanoparticles are highly reactive toward biological 
surfaces and structures [2]. Although particles deposited 
on the skin tend not to penetrate beyond the upper layers 
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Abstract
Background/Aims: Airborne pollutants, such as nano-sized 
soot particles, are increasingly being released into the envi-
ronment as a result of growing population densities and in-
dustrialization. They can absorb organic and metal com-
pounds with potential biological activity, such as polycyclic 
aromatic hydrocarbons and airborne pollen allergens. Local 
and systemic toxicities may be induced in the skin if the par-
ticulates release their harmful components upon dermal 
contact. Methods: In the present study, skin pretreatments 
with serum and/or shield as barrier formulations prior to ex-
posure and washing with a cleanser subsequent to exposure 
were evaluated as a protection and decontamination strat-
egy using laser scanning microscopy. Results: The results in-
dicate that while the application of serum and a cleanser was 
insufficient for decontamination, the pretreatment with 
shield prior to nanoparticle exposure followed by washing 
led to the removal of a considerable amount of the carbon 
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of the stratum corneum [3], they have been reported to 
readily accumulate in the follicular ducts [4], from where 
active substances may be released and translocated to 
deeper skin layers and into tissues surrounding the hair 
follicles and cells. Particulate contaminants such as soot 
have been shown to be associated with a higher risk for 
cancer [5, 6], pulmonary and cardiovascular diseases [6, 
7], and harmful effects to human skin [2, 8, 9]. They can 
absorb organic chemicals such as polycyclic aromatic hy-
drocarbons and metals, which are capable of localizing in 
mitochondria and generating reactive oxygen species [8], 
and penetrate cellular targets in the lung and systemic cir-
culation [10]. In particular, polycyclic aromatic hydrocar-
bons appear to be key compounds in the toxicity of ambi-
ent nanoparticles [2]. Pollen allergens have been shown to 
exacerbate skin conditions in atopic eczema patients and 
pass through a disrupted skin barrier and can be taken up 
by Langerhans cells in vitro [11]. Air pollution has also 
been significantly correlated with extrinsic skin aging, in 
particular to pigment spots and wrinkles [2]. Textile cov-
ering of the skin can provide protection against the detri-
mental effect of these particles. As some skin areas, such 
as the face and hands, remain continuously exposed, spe-
cific protective strategies should be developed, particular-
ly for areas with high concentrations of airborne nano-
sized pollutants. Decontamination of skin exposed to such 
potentially harmful particulates is therefore critical for re-
ducing the risk of local and systemic toxicity. Currently, 
the most widely available cleansing strategy is washing 
with soap and water [12]. However, this strategy presents 
several limitations for persons exposed to high concentra-
tions of potentially harmful particles (i.e., radioactive 
dust) or the population in extremely dust-polluted areas 
including metropolises such as Beijing, and may even re-
sult in the enhanced permeation and systemic absorption 
of the harmful substances [13, 14]. The administration of 
barrier shields that seal the skin surface while guarantee-
ing an adequate moisture regulation between the skin and 
the environment prior to exposure and washing of the 
skin after exposure provides a more suitable option for 
persons subject to high-risk exposure [15]. The present 
study aimed at investigating whether skin care products 
can prevent the penetration of potentially harmful parti-
cles into the skin and contribute to their removal from the 
skin surface. Pretreatments of the skin with serum and/or 
shield and washing with a cleanser after contamination 
with model particulate contaminants, i.e., carbon black 
particles, were therefore evaluated as an alternative pro-




The experiments were performed ex vivo on skin obtained 
from 6 pairs of porcine ears provided by a local butcher and 2 hu-
man skin samples excised from the abdomen of patients who had 
undergone cosmetic reduction surgery at the Charité – Univer-
sitätsmedizin Berlin. All experiments were conducted within 24 h 
of excision. Visibly diseased, injured, or scarred skin was not in-
cluded in the study. Prior to the treatments, the excised ears and 
the human skin samples were rinsed with cold water and dabbed 
dry using paper towels so as not to injure the skin surface, and 
subsequently maintained at an ambient temperature and humid-
ity. Four test areas sized 4 × 4 cm were marked on the dorsal side 
of each ear belonging to the same animal with silicone barriers, 
providing a total of 8 test areas per pair of ears. Eight test areas 
were marked in the same manner on each human skin sample. 
The allocation of the test areas was randomized. Approval for the 
experiments on porcine ear skin was obtained from the Veteri-
nary Board of Control (Veterinäramt Treptow-Köpenick, Berlin, 
Germany). Approval for the investigations using excised human 
skin samples were obtained from the Ethics Committee of the 
Charité – Universitätsmedizin Berlin.
Test Formulations and Model Contaminants
The serum (ref. 5189002000), shield (Crème Solaire ref. 
5240001000), and cleanser (ref. 4949002000) implemented in the 
investigations were provided by Coty Lancaster SAM (Interna-
tional R & D Center, Monaco, Monaco). The serum was comprised 
of siloxane derivatives and xanthan gum associated with alkyl ac-
rylate cross-polymers and alcohol. It had a light emulsion-gel tex-
ture which resulted in a soft and smooth film on the skin surface. 
The shield was a light fluid oil-in-water emulsion including a hy-
droxyethyl acrylate/sodium acryloyldimethyltaurate copolymer 
gel and 2 surfactant tribehenin polyethylene glycol (PEG)-20 esters 
combined with PEG-100 stearate and glyceryl stearate. It also in-
cluded UV-A and UV-B filters with a 1: 3 ratio. The cleanser was a 
white lightweight creamy foam which consisted of C12 to C16 fatty 
acids combined with a mild sodium cocoyl glycinate tenside. 1% 
fluorescein (Fluoreszein SE Thilo, Alcon Pharma GmbH, Freiburg, 
Germany) was mixed homogenously into the serum and shield 
prior to their use to enable visualization of their distribution on the 
skin surface by LSM. Fluorescein was administered to the test re-
gions of the controls so as to similarly visualize their surfaces using 
the confocal microscope. Carbon black particles (150 nm), imple-
mented as model contaminants, were obtained from the Leibniz 
Research Institute for Environmental Medicine (Düsseldorf, Ger-
many).
Application Protocols
For each application protocol, 2 test areas were allocated. These 
were either dusted with carbon black particles and used as con-
trols, or pretreated with serum, shield, or both and then dusted 
with carbon black particles. After application of the model con-
taminants with a penetration time of 5 min, 1 of the test areas al-
located to each application protocol was washed using the cleans-
er. A pea-sized amount of cleanser was frothed up with 1 mL water 
prior to being dabbed onto the skin, after which it was washed off 
under cool running water until all traces of foam were removed 
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ly for 10 min while the shield required 30 min to dry. All experi-
ments were conducted at room temperature (19 ° C ± 4 ° C).
Control
One drop of fluorescein was administered to the control test 
areas and allowed to penetrate for 2 min. Carbon black particles 
(0.1 mg/cm2) were lightly dusted onto the test regions. One of the 
test areas was subsequently washed with a small amount of cleans-
er under running water.
Serum
Serum mixed with 1% fluorescein (2 mg/cm2) was applied top-
ically to the serum test areas and dispersed homogenously using a 
gloved finger. After 10 min, carbon black particles (0.1 mg/cm2) 
were lightly dusted onto the treated and dried test areas, and 1 of 
the test areas was washed using the cleanser under running water.
Shield
Shield mixed with 1% fluorescein (2 mg/cm2) was administered 
homogenously to the test areas using a gloved finger. Carbon black 
particles (0.1 mg/cm2) were lightly dusted onto both dried test re-
gions after a contact time of 30 min and subsequently washed off 
with the cleanser under running water from 1 of the test regions.
Combination Serum/Shield
Serum mixed with fluorescein (2 mg/cm2) was topically applied 
to the test areas and allowed to dry for 10 min, after which shield 
mixed with fluorescein (2 mg/cm2) was administered. This was 
also allowed to dry. After 30 min, carbon black particles (0.1 mg/
cm2) were applied to the skin and washed off from 1 of the test ar-
eas using the cleanser and running water.
Laser Scanning Microscopy
A reflectance confocal LSM (VivaScope® 1500, MAVIG 
GmbH, Munich, Germany) was used to conduct the present inves-
tigations. The VivaScope® implements a laser beam at a wave-
length of 445 nm to visualize horizontal skin sections noninva-
sively. The single test field of view is 500 × 500 µm2. The optical 
resolution is <1.25 µm in the center of the image field horizontally 
and <5 µm in the center of the image field vertically. Cellular details 
can be depicted at high spatial resolution and good contrast with-
out necessitating a biopsy and further histological processing or 
staining. The technique is described in detail in Meyer and Lade-
mann [16]. In the present study, single confocal images of horizon-
tal sections of the skin were obtained. The laser intensity was ad-
justed manually to achieve images with a suitable contrast of the 
dermal structures. LSM images of all test samples were taken sub-
sequently to the specific pretreatments with the serum, shield, and 
particle contaminants and prior to washing, as well as after wash-
ing of the skin samples, i.e., porcine ear skin and human ex vivo 
skin, using the cleanser.
Results and Discussion
Unwanted and noxious airborne particles found in the 
environment are formed during combustion or industri-
al production processes, and can cause a wide range of 
health problems [17]. Occupationally exposed persons or 
persons living in highly polluted regions are particularly 
at risk. Although particles deposited on the skin mostly 
remain in the uppermost layers of the stratum corneum 
[3], they may accumulate in susceptible skin appendages, 
such as the hair follicles [4], from where diffusion of the 
noxious substances from the particulates could result in 
their translocation into deeper skin layers and the tissues 
surrounding the hair follicles and cells, including the skin 
vasculature. In the present study, carbon black particles, 
implemented as model contaminants, were administered 
to porcine ear skin and ex vivo human skin subsequent to 
pretreatments with serum and/or shield, after which a 
cleansing agent was utilized for washing of the treated 
skin. LSM investigations were conducted to evaluate the 
efficacy of the different protection and decontamination 
procedures by examining the test regions for the presence 
of carbon black particles.
a b
Fig. 1. a, b Distribution of carbon black 
particles (black spots) on the skin surface of 
porcine ear skin (a) and human ex vivo 

























   
   
   
   
   

























Figure 1a and b represents LSM images of the distri-
bution of carbon black particles on the skin surface of 
porcine ear skin and human ex vivo skin subsequent to 
their topical application, respectively.
In both porcine (Fig.  2a) and human ex vivo skin 
(Fig.  2b), washing using the cleanser resulted in only 
a slight reduction of the carbon black particles on the 





Fig. 2. a, b Distribution of carbon black 
particles (black spots) on the skin surface of 
porcine ear skin (a) and human ex vivo 
skin (b) after washing.
Fig. 3. a, b Distribution of carbon black 
particles (black spots) on the skin surface of 
porcine ear skin (a) and human ex vivo 
skin (b) pretreated with serum. 
Fig. 4. a, b Distribution of carbon black 
particles (black spots) on the skin surface of 
porcine ear skin (a) and human ex vivo 
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Pretreatment of the porcine ear skin and human ex 
vivo skin with serum resulted in the formation of a con-
fluent serum film on the stratum corneum. The distribu-
tion of the carbon black particles, which were applied top-
ically subsequently to the serum, are shown in Figure 3a 
and b for porcine ear skin and human ex vivo skin, respec-
tively.
After washing, a small amount of residual carbon black 
particles was still detectable on the porcine (Fig. 4a) and 
human ex vivo skin (Fig. 4b) samples.
Shield
As in the case of serum application, the administration 
of shield resulted in the formation of a confluent shield 
film on the surface of the porcine ear skin samples. The 
distribution of the carbon black particles on pig skin and 
human skin pretreated with shield is shown in Figure 5a 
and b, respectively.
Washing of skin pretreated with shield using the 
cleanser resulted in a more pronounced reduction of the 
carbon black particles from the skin surface in porcine ear 
skin (Fig. 6a) and human ex vivo skin (Fig. 6b) compared 
to the pretreatment with serum.
Combination Serum/Shield
Serum and shield were consecutively applied onto the 
porcine ear skin samples and human ex vivo skin, which 
also resulted in the formation of a confluent film on the 
horny layer. The distribution of the deposited carbon 
black particles on the skin pretreated with both shield and 
serum is shown in Figure 7a and b, respectively. 
Subsequent washing with the cleanser resulted in the 
elimination of the confluent film and the particulate con-
taminants from the skin surface, which were no longer 




Fig. 5. a, b Distribution of carbon black 
particles (black spots) on the skin surface of 
porcine ear skin (a) and human ex vivo 
skin (b) pretreated with shield.
Fig. 6. a, b Only traces of carbon black par-
ticles (black spots) are detectable on the 
skin surface of porcine ear skin (a) and hu-
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Skin barrier formulations are designed to reduce or 
prevent penetration and absorption of irritants and al-
lergens into the skin of highly exposed persons by pre-
senting a physical barrier, i.e., a thin film, between the 
skin and the contaminant [18]. Many in vivo and in vitro 
investigations have been performed using animal and 
human skin to test the efficacy of barrier formulations as 
pre-exposure skin protectors [15, 19–21]. The common-
ly quoted general rule is that water-in-oil emulsions are 
effective against aqueous solutions of contaminants and 
oil-in-water emulsions are effective against lipophilic 
substances [22, 23], with few exceptions [21, 24]. The 
protective film may interfere with absorption and pene-
tration by trapping the contaminants, e.g. previous in-
vestigations have shown that the penetration of pollen 
allergens into hair follicles was significantly reduced 
when the skin had been treated with commercial care 
products [25]. The present work illustrated that while 
topical pretreatments of exposed skin with serum or 
shield followed by washing subsequently to contamina-
tion facilitated the removal of a large portion of the de-
posited particulate contaminants from the skin, the com-
bined use of the serum and shield with a cleanser result-
ed in the most efficient barrier effect in porcine and 
human skin samples. The serum and shield were applied 
before the skin was exposed to the carbon black particles, 
therefore acting as barrier-enhancing formulations. The 
topical application of the serum and the shield resulted 
in a confluent film on the surface of the skin samples, 
covering the furrows and wrinkles. This effect was more 
pronounced for the shield and facilitated the removal of 
the carbon black particles from the skin surfaces when 
the serum was used in combination with the shield. 
Highly exposed persons could implement this protection 
strategy to successfully minimize exposure to harmful 
particulates. In a previous study, the silicone glycol poly-
mer PEG-12 dimethicone and an absorbent textile mate-
rial based on nanofibers were used to remove topically 
a b
a b
Fig. 7. a, b Distribution of carbon black 
particles (black spots) on the skin surface of 
porcine ear skin (a) and human ex vivo 
skin (b) pretreated with the combination of 
serum and shield.
Fig. 8. a, b The confluent film and the car-
bon black particles (black spots) were no 
longer detectable on the skin surface of 
porcine ear skin (a) and human ex vivo 
skin (b) pretreated with the combination of 
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applied fluorescing hydroxyethyl starch nanocapsules 
implemented as model contaminants from porcine ear 
skin [26]. While the absorbent textile materials alone did 
not result in sufficient decontamination, PEG-12 di-
methicone acted as a wetting agent, transferring the 
nanocapsules into a liquid phase which was subsequent-
ly taken up by the absorbent textile material. Similarly, 
the carbon black particles implemented in the present 
study deposited on the film comprised of the serum and 
shield, which facilitated their removal from the skin sur-
face upon washing [23]. In the present study, LSM inves-
tigations were conducted to visualize the effect of barrier 
formulations in facilitating the removal of carbon black 
particles from the skin surface using a washing agent. 
The combined use of serum and shield provided a more 
complete barrier function than the individual applica-
tions of the serum or the shield, whereby the shield was 
comparably more effective than the serum. To ensure 
that no penetration of the particulates occurred, i.e., into 
the hair follicle openings, which has been described pre-
viously [27], further histological investigations would be 
necessary. Through this pathway, ambient nanoparticles 
may be able to reach deeper skin layers, releasing surface-
bound compounds such as polycyclic aromatic hydro-
carbons, directly affecting the function of skin cells [2] 
and gaining access to the circulatory system.
Conclusions
Removal of particulate contaminants such as soot par-
ticles from the skin is essential for preventing further per-
meation of harmful compounds, i.e., absorbed organic or 
metal compounds. In the present study, the efficacies of 
different application procedures using serum, shield, and 
a cleanser for protecting against and removing topically 
applied carbon black particles from the skin surface were 
evaluated using LSM. Similar results were obtained for 
porcine ear and human ex vivo skin. The findings indi-
cated that while the application of serum and a cleanser 
was insufficient, and a large amount of particles could still 
be found on the skin, the pretreatment with shield and 
subsequent washing led to the removal of a considerable 
amount of the carbon black particles. The combined ap-
plication of serum and shield, followed by washing, led to 
the complete elimination of the carbon black particles 
from the skin samples. Persons exposed to high amounts 
of pollutants could thereby benefit not only from textile 
covering, etc., but also from the application of effective 
barrier-enhancing formulations in combination with a 
cleanser to reduce the invasion of harmful particulates 
into the skin and improve the skin barrier.
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